| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
PD 114595
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: benzothiopyrano-indazole cpd; structure given in first source
Also Known As:PD-114595; 2H-(1)Benzothiopyrano(4,3,2-cd)indazol-9-ol, 2-(2-(diethylamino)ethyl)-5-((2-((2-hydroxyethyl)amino)ethyl)amino)-
Bio-Agent Context: Research Results
Related Diseases
| 1. | Neoplasms (Cancer)
01/01/1988
- "Cl-958, PD 121373, and PD 114595 belong to a new class of DNA complexers, substituted 2H-[1]benzothiopyrano[4,3,2-cd] indazoles, and are being further developed as antitumor drugs based on their curative properties against murine solid tumor models"
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Indazoles
|
| 2. | DNA (Deoxyribonucleic Acid)
|
| 3. | Antineoplastic Agents (Antineoplastics)
|
| 4. | Cl958
|
| 5. | PD 121373
|
| 5 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |